Feasibility Trial Using an Inpatient Insulin Dosing Calculator

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-22

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this feasibility trial is to test whether a novel insulin dosing calculator can improve blood glucose management for patients with type 2 diabetes mellitus on hospital admission. The main questions it aims to answer are:

* Whether using this calculator leads to no excessive hypoglycemia?
* Whether using this calculator leads to a decrease of hyperglycemia?

Participants will receive initial insulin doses by the calculator on hospital admission, and the rest of care will follow standard of care. Participants will be compared with patients in the UW observational cohort who received initial insulin doses by standard of care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

NCT00115973

Diabetes Diabetes Mellitus, Type 2 Delivery Systems

COMPLETED PHASE1

A Comparison of Two Initial Dosing Formulas

NCT01377155

Diabetes Mellitus, Type 2

COMPLETED NA

Feasibility Study of an Integrated Sensor and Infusion Set

NCT01770561

Diabetes Type 1

COMPLETED NA

Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes

NCT01170208

Diabetes Insulin

COMPLETED NA

Safety and Feasibility of an Insulin Sensitivity-Informed Bolus Calculator in Type 1 Diabetes

NCT03709108

Type 1 Diabetes Mellitus

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Insulin dosing calculator

Group Type EXPERIMENTAL

Initial insulin dosing using the calculator

Intervention Type OTHER

Participants will receive initial insulin doses by the calculator on hospital admission.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Initial insulin dosing using the calculator

Participants will receive initial insulin doses by the calculator on hospital admission.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are admitted to University of Washington Medical Centers
* With history of type 2 and/or steroid-induced diabetes mellitus
* Receiving insulin therapy prior to admission

Exclusion Criteria

* Patients who are admitted to ICU or obstetrics ward
* Patients who are admitted for elective surgery or procedure
* Patients who present with diabetic ketone acidosis, hyperosmolar hyperglycemic state or require intravenous insulin infusion
* Patients who have no meal intake for 24 hours prior to admission, or planned nothing per oral (NPO) during the first 24 hours after admission
* Patients who report low appetite (25% or less) on admission or have a significantly decreased level of consciousness that they unlikely eat right after admission
* Patients who receive enteral feeding after admission
* Patients who develop severe acute kidney injury needing dialysis therapy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No